Kura Oncology Inc (NASDAQ:KURA)
| 13.62 Delayed Data As of 3:59pm ET |  -0.39 / -2.78%Today’s Change | 10.41 Today|||52-Week Range 19.93 | +9.75% Year-to-Date |
Institutional investors purchased a net $3.3 million shares of KURA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 103.98% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 69.90% |
| Mutual fund holders | 34.08% |
| Individual stakeholders | 12.47% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/05/2022 | BVF PARTNERS LP Bought 343.3 Thousand shares of Kura Oncology Inc |
| 12/31/2022 | HENNION & WALSH ASSET MANAGEMENT... Bought 6.4 Thousand shares of Kura Oncology Inc |
| 1/05/2023 | MIRAE ASSET GLOBAL INVESTMENTS C... Bought 11.00 shares of Kura Oncology Inc |
Top 10 Owners of Kura Oncology Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Ecor1 Capital LLC | 9.73% | 6,638,371 | 82,382,184 | 0 | 0.00% |
| SSgA Funds Management, Inc. | 6.40% | 4,368,763 | 54,216,349 | +1,337,149 | +44.11% |
| BlackRock Fund Advisors | 6.29% | 4,294,678 | 53,296,954 | -96,230 | -2.19% |
| Suvretta Capital Management LLC | 5.95% | 4,063,128 | 50,423,418 | +46,128 | +1.15% |
| BVF Partners LP | 5.20% | 3,547,083 | 44,019,300 | +343,300 | +10.72% |
| Avoro Capital Advisor LLC | 5.16% | 3,525,000 | 43,745,250 | -1,275,000 | -26.56% |
| Holocene Advisors, LP | 5.09% | 3,476,105 | 43,138,463 | +218,809 | +6.72% |
| The Vanguard Group, Inc. | 4.72% | 3,221,738 | 39,981,769 | -44,873 | -1.37% |
| Deep Track Capital LP | 4.67% | 3,186,083 | 39,539,290 | -511,886 | -13.84% |
| T. Rowe Price Investment Manageme... | 3.77% | 2,572,169 | 31,920,617 | +2,572,169 | -- |
Top 10 Mutual Funds Holding Kura Oncology Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 4.71% | 3,215,769 | 39,907,693 | +12,992 | +0.41% |
| Vanguard Total Stock Market Index... | 2.89% | 1,969,608 | 24,442,835 | +77,000 | +4.07% |
| iShares Russell 2000 ETF | 2.11% | 1,441,843 | 17,893,272 | -15,067 | -1.03% |
| Vanguard Extended Market Index Fu... | 1.24% | 848,398 | 10,528,619 | +6,095 | +0.72% |
| T Rowe Price Small Cap Value Fund | 1.17% | 797,818 | 9,900,921 | -89,800 | -10.12% |
| T Rowe Price Small Cap Stock Fund | 1.00% | 685,267 | 8,504,163 | +54,100 | +8.57% |
| iShares Russell 2000 Value ETF | 0.99% | 677,934 | 8,413,161 | -4,367 | -0.64% |
| Franklin Small Cap Growth Fund | 0.84% | 571,700 | 7,094,797 | 0 | 0.00% |
| iShares Biotechnology ETF | 0.79% | 540,355 | 6,705,806 | +2,030 | +0.38% |
| Fidelity Small Cap Index Fund | 0.73% | 501,162 | 6,219,420 | +7,093 | +1.44% |